Changes in Natriuretic Peptide Levels and Cardiac Structure in Patients Treated With Vericiguat
Background: Changes in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels and cardiac remodeling from baseline to follow-up in patients with heart failure with reduced ejection fraction (HFrEF) treated with vericiguat remain unclear.
Authors
- Kenji Kanenawa (ORCID: https://orcid.org/0000-0002-9276-327X)
- Koshiro Kanaoka (ORCID: https://orcid.org/0000-0001-7900-7835)
- Takahito Nasu (ORCID: https://orcid.org/0000-0001-5631-6870)
- Takeshi Ijichi (ORCID: https://orcid.org/0000-0002-1950-7616)
- Shunsuke Ishii (ORCID: https://orcid.org/0000-0003-2111-6304)
- Shingo Matsumoto (ORCID: https://orcid.org/0000-0003-3774-5973)
- Gaku Nakazawa (ORCID: https://orcid.org/0000-0003-2315-9658)
- Yasuyuki Shiraishi (ORCID: https://orcid.org/0000-0001-8788-1186)
- N Kagiyama
- Wataru Fujimoto
- Kenji Ando
- VERIFY-HF Investigators
Institutions
- Toho University (JP)
- Tokai University (JP)
- Iwate Medical University (JP)
- Keio University (JP)
- Juntendo University (JP)
- Hyogo Prefectural Awaji Medical Center (JP)
- National Cerebral and Cardiovascular Center (JP)
- Health Information Management (BE)
- Kokura Memorial Hospital (JP)
- Kitasato University (JP)
- Nara Medical University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1253/circj.cj-25-1087
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00